GIKLY
Price
$4.62
Change
+$0.03 (+0.65%)
Updated
Jan 17 closing price
Capitalization
8.78B
39 days until earnings call
KYKOF
Price
$13.28
Change
-$1.72 (-11.47%)
Updated
Jan 16 closing price
Capitalization
10.37B
Ad is loading...

GIKLY vs KYKOF

Header iconGIKLY vs KYKOF Comparison
Open Charts GIKLY vs KYKOFBanner chart's image
Grifols Sa
Price$4.62
Change+$0.03 (+0.65%)
Volume$1.2K
Capitalization8.78B
Kyowa Hakko Kogyo
Price$13.28
Change-$1.72 (-11.47%)
Volume$100
Capitalization10.37B
GIKLY vs KYKOF Comparison Chart
Loading...
GIKLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYKOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GIKLY vs. KYKOF commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GIKLY is a Hold and KYKOF is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (GIKLY: $4.62 vs. KYKOF: $13.28)
Brand notoriety: GIKLY and KYKOF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GIKLY: 10% vs. KYKOF: 24%
Market capitalization -- GIKLY: $8.78B vs. KYKOF: $10.37B
GIKLY [@Pharmaceuticals: Major] is valued at $8.78B. KYKOF’s [@Pharmaceuticals: Major] market capitalization is $10.37B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GIKLY’s FA Score shows that 1 FA rating(s) are green whileKYKOF’s FA Score has 1 green FA rating(s).

  • GIKLY’s FA Score: 1 green, 4 red.
  • KYKOF’s FA Score: 1 green, 4 red.
According to our system of comparison, both GIKLY and KYKOF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GIKLY’s TA Score shows that 3 TA indicator(s) are bullish while KYKOF’s TA Score has 3 bullish TA indicator(s).

  • GIKLY’s TA Score: 3 bullish, 0 bearish.
  • KYKOF’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, GIKLY is a better buy in the short-term than KYKOF.

Price Growth

GIKLY (@Pharmaceuticals: Major) experienced а -2.32% price change this week, while KYKOF (@Pharmaceuticals: Major) price change was -11.45% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.03%. For the same industry, the average monthly price growth was -0.28%, and the average quarterly price growth was -6.86%.

Reported Earning Dates

GIKLY is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.03% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYKOF($10.4B) has a higher market cap than GIKLY($8.79B). GIKLY has higher P/E ratio than KYKOF: GIKLY (75.19) vs KYKOF (29.33). GIKLY YTD gains are higher at: -1.745 vs. KYKOF (-11.445). KYKOF has higher annual earnings (EBITDA): 83.6B vs. GIKLY (726M). KYKOF has more cash in the bank: 347B vs. GIKLY (557M). KYKOF has less debt than GIKLY: KYKOF (5.55B) vs GIKLY (10.9B). KYKOF has higher revenues than GIKLY: KYKOF (404B) vs GIKLY (6.46B).
GIKLYKYKOFGIKLY / KYKOF
Capitalization8.79B10.4B84%
EBITDA726M83.6B1%
Gain YTD-1.745-11.44515%
P/E Ratio75.1929.33256%
Revenue6.46B404B2%
Total Cash557M347B0%
Total Debt10.9B5.55B197%
FUNDAMENTALS RATINGS
GIKLY vs KYKOF: Fundamental Ratings
GIKLY
KYKOF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
18
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8762
PRICE GROWTH RATING
1..100
6288
P/E GROWTH RATING
1..100
9794
SEASONALITY SCORE
1..100
5014

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KYKOF's Valuation (18) in the null industry is in the same range as GIKLY (20). This means that KYKOF’s stock grew similarly to GIKLY’s over the last 12 months.

KYKOF's Profit vs Risk Rating (100) in the null industry is in the same range as GIKLY (100). This means that KYKOF’s stock grew similarly to GIKLY’s over the last 12 months.

KYKOF's SMR Rating (62) in the null industry is in the same range as GIKLY (87). This means that KYKOF’s stock grew similarly to GIKLY’s over the last 12 months.

GIKLY's Price Growth Rating (62) in the null industry is in the same range as KYKOF (88). This means that GIKLY’s stock grew similarly to KYKOF’s over the last 12 months.

KYKOF's P/E Growth Rating (94) in the null industry is in the same range as GIKLY (97). This means that KYKOF’s stock grew similarly to GIKLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GIKLYKYKOF
RSI
ODDS (%)
N/A
Bullish Trend 12 days ago
18%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
49%
Bearish Trend 12 days ago
14%
Momentum
ODDS (%)
Bullish Trend 12 days ago
55%
Bullish Trend 12 days ago
23%
MACD
ODDS (%)
N/A
Bullish Trend 12 days ago
24%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
47%
Bullish Trend 12 days ago
24%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
53%
Bearish Trend 12 days ago
33%
Advances
ODDS (%)
Bullish Trend 14 days ago
69%
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 12 days ago
27%
View a ticker or compare two or three
Ad is loading...
GIKLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYKOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
STAFX40.570.44
+1.10%
Allspring Large Cap Growth A
JLPYX21.950.23
+1.06%
JPMorgan US Large Cap Core Plus R6
HSUTX66.980.65
+0.98%
Rational Dynamic Brands Instl
NEFFX63.320.57
+0.91%
American Funds New Economy F2
PASIX10.570.02
+0.19%
PACE Alternative Strategies A

GIKLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, GIKLY has been closely correlated with GRFS. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if GIKLY jumps, then GRFS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GIKLY
1D Price
Change %
GIKLY100%
+0.61%
GRFS - GIKLY
68%
Closely correlated
+0.41%
GIFOF - GIKLY
27%
Poorly correlated
N/A
GIFLF - GIKLY
25%
Poorly correlated
N/A
ORINY - GIKLY
9%
Poorly correlated
+0.20%
OPHLY - GIKLY
8%
Poorly correlated
N/A
More

KYKOF and

Correlation & Price change

A.I.dvisor tells us that KYKOF and OPHLY have been poorly correlated (+12% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KYKOF and OPHLY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYKOF
1D Price
Change %
KYKOF100%
N/A
OPHLY - KYKOF
12%
Poorly correlated
N/A
NVSEF - KYKOF
7%
Poorly correlated
-1.28%
GIKLY - KYKOF
4%
Poorly correlated
+0.61%
MAYNF - KYKOF
-1%
Poorly correlated
N/A
HAWPF - KYKOF
-1%
Poorly correlated
N/A
More